Circulation APC and Open Access: Current AHA Hybrid Pricing, Coverage, and When to Pay

The official AHA author guidance confirms the part authors most need for planning:

• Circulation is not fully open access
• authors can still use the subscription route
• open access is available through the journal's publishing workflow after acceptance

The pricing problem is that AHA and Wolters Kluwer do not expose a clean, stable public sticker page for Circulation in the same way some other publishers do. That means the honest planning answer is a public range, not a fake precision number. In practice, current researcher and library planning around Circulation still lands in the mid-$4,000 band, usually described as about $4,000 to $5,000.

That is good enough to make the real decision:

1. whether your institution has AHA or publisher-side coverage
2. whether your funder requires immediate OA
3. whether the paper is strong enough that paying for immediate access is rational

The APC question at Circulation is not about whether the journal is visible enough. It is about whether immediate unrestricted access adds enough value beyond an already dominant subscription venue.

The current direction is slightly positive. Circulation is up from 37.8 in 2023 to 38.6 in 2024. That matters because it shows the flagship cardiology position held after the pandemic-era spike rather than collapsing back toward the pre-2020 band.

Circulation is still one of the clearer cases where not paying is often defensible.

Subscription route

• no APC
• standard publication route
• still reaches the core cardiology readership because Circulation has very deep institutional penetration

Open-access route

• APC applies after acceptance
• usually justified by funder rules, institutional coverage, or a strong need for unrestricted immediate access

Agreement and waiver reality

• some authors will have institutional support through publisher-side arrangements
• authors from lower-resource settings may qualify for waiver or discount pathways
• exact outcome is not universal, so authors should check the library first rather than assume anything from a Springer Nature or Elsevier deal

In our pre-submission review work, the APC is rarely the thing that causes regret.

The expensive mistake is paying attention to open-access mechanics before checking whether the manuscript is really broad enough for Circulation.

The repeat failure pattern is:

• strong cardiology science
• but too subspecialty-facing
• with a cover letter that leans on journal prestige instead of audience fit

If that sounds familiar, the better question is not "can we afford Circulation OA?" It is "should this be in Circulation at all?" A fast submission readiness check is usually more useful than another round of APC planning.

The honest answer for Circulation APC is not a fake single number. It is:

• hybrid journal
• subscription route still available at $0
• current public OA planning range roughly $4,000 to $5,000
• actual invoice depends on workflow details and coverage

That is enough to plan rationally. If the paper is truly Circulation-level and the funding path is solved, paying for OA can make sense. If either of those conditions is weak, the APC discussion is early.